ARCHIVES

Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 24 | June 11, 2014

Download PDF Visit The Full Archive

Related Articles

NCI, Six Centers Begin Feasibility Study Of Spiral CT For Lung Cancer Screening.

September 8, 2000

Patients urge Medicare to allow an open formulary for cancer treatment.

October 15, 2004

Toxicology Program Seeks Comment On Substances.

March 23, 2001

Breast Cancer A Heterogeneous Disease, Concepts Changing: Fisher

June 13, 1980

ACS-Roosevelt Fellows Announced

July 29, 1977

NIH Accepting FIRST Applications

May 2, 1986